Small Cell Lung Cancer Renal Cell Carcinoma Choose Specialty December 7, 2019 BySilas Inman Article Conference|ASH Annual Meeting Patients with refractory large B-cell lymphoma who were treated with Axi-cel had a 3-year overall survival rate of 47%, according to an updated analysis of ...
diffuse large- B-cell lymphoma Jie Sun*, Liang Cheng*, Hongbo Shi*, Zhaoyue Zhang, Hengqiang Zhao, Zhenzhen Wang & Meng Zhou Long non-coding RNAs (lncRNAs) represent an emerging layer of cancer biology and have been implicated in the development and progression of cancers. ...
2023年9月,赵维莅教授团队在《Cancer Cell》杂志在线发表题名为“Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial”——弥漫性大B细胞淋巴瘤基于基因分型的R-CHOP-X方案:...
Primary gastric diffuse large B-cell lymphoma, Cancer-specific survival rate, Nomogram, Web survival rate calculator, Dynamically predictBackgroundThis study investigated a large number of patients to develop a predictive nomogram for survival and a web-based survival rate calculator that can dynamically...
B-cell lymphomais a common subtype of non-Hodgkin lymphoma (NHL), which is the seventh-most prevalent cancer in the United States and has the sixth-highestmortality rate[1]. The most frequently diagnosed B-cell lymphoma subtypes include diffuse large B-cell lymphoma (DLBCL; 31% of diagnosed...
Lymphomas are a heterogeneous group of lymphoproliferative disorders, with unique clinical and biological characteristics that exhibit variable response to therapy. Advances in chemo-immunotherapy have improved outcomes in a number of lymphoma subtypes;
To explain the excess cancer rate in males, several candidates for “escape from X-inactivation tumor-suppressor” (EXITS) were recently identified. In this report we provide direct experimental evidence supporting UTX’s role as an EXITS gene. Using a mouse lymphoma model, we show clear dosage...
signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method.We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We...
弥漫大B细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)是一组大细胞、侵袭性的恶性淋巴瘤,是成人淋巴瘤中最常见的类型,约占所有淋巴瘤的40%。DLBCL在临床表现、组织形态和预后等多方面具有高度异质性。DLBCL最初被分为三个亚型:ABC(activated B cell-like)、GCB(germinal center B cell-like)和Unclassified【...
Desai S, Maurin M, Smith MA, et al. PRDM1 is required for mantle cell lymphoma response to bortezomib[J]. Mol Cancer Res, 2010, 8(6): 907-918. DOI:10.1158/1541-7786.MCR-10-0131 [9] Pasqualucci L, Compagno M, Houldsworth J, et a...